High bone turnover elevates the risk of denosumab-induced hypocalcemia in women with postmenopausal osteoporosis
Koji Ishikawa,1 Takashi Nagai,1 Keizo Sakamoto,1 Kenji Ohara,2 Takeshi Eguro,1,2 Hiroshi Ito,1 Yoichi Toyoshima,1 Akatsuki Kokaze,3 Tomoaki Toyone,1 Katsunori Inagaki1 1Department of Orthopaedic Surgery, Showa University School of Medicine, Tokyo, 2Department of Orthopaedic Surgery, Yamanashi Red Cr...
Saved in:
Main Authors: | Ishikawa K (Author), Nagai T (Author), Sakamoto K (Author), Ohara K (Author), Eguro T (Author), Ito H (Author), Toyoshima Y (Author), Kokaze A (Author), Toyone T (Author), Inagaki K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Denosumab in Osteoporosis or Low Bone Mineral Density Postmenopausal Women
by: Yi Chen, et al.
Published: (2021) -
Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
by: Darbà J, et al.
Published: (2015) -
Update on denosumab in the management of postmenopausal osteoporosis: patient preference and adherence
by: Cairoli E, et al.
Published: (2015) -
The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis
by: Murat Uludağ, et al.
Published: (2013) -
Economic Evaluation of Denosumab for Treatment of Postmenopausal Osteoporosis: A Systematic Review
by: Shahin Nargesi, et al.
Published: (2022)